Alexander S. Yevzlin
Member of Scientific Advisory BoardDr. Alexander S. Yevzlin, MD, FASN, also known as Alex, serves as Member of Scientific Advisory Board at Sigyn Therapeutics, Inc. since March 2022. Dr. Yevzlin’s considerable extracorporeal industry experience and insight is expected to contribute to the clinical advancement of Sigyn Therapy. He is a Chief Medical Officer at Sonavex, Inc. He serves as a CMO and Director of Zartico, Inc. He founded Phraxis, Inc., in 2008 and serves as its Director and CEO and served as its Chief Scientific Officer. Dr. Yevzlin is the Founder of several start-up companies and has served in the roles of CMO and CSO. He is an internationally recognized leader in the field of Interventional Nephrology, having edited the first three textbooks on the subject and is a past President of the American Society of Diagnostic and Interventional Nephrology. Dr. Yevzlin is a seasoned entrepreneur, co-founding Phraxis Inc and R4 Vascular and has served as Chief Medical Officer for Cytopherx and AV-Medical. Along with his academic contributions, Dr. Yevzlin has been involved in the invention, design and reduction to practice of multiple medical devices in his role as chief medical officer, chief science officer and founder of multiple start-up biotech companies. Dr. Yevzlin also served as Vice Chair of the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) committee, responsible for the Clinical Practice Guidelines for Vascular Access. He is a board member in the vascular access space. He is the inventor of the Phraxis technology. He serves as an Associate Professor of Medicine at University of Wisconsin and Director of Interventional Nephrology and CKD clinic. He has published or presented over 150 manuscripts, abstracts and invited lectures. After receiving his BA degree magna cum laude from Dartmouth College Dr. Yevzlin attended medical school at Ohio State University, internship and residency training in Internal Medicine at the University of Michigan and his Nephrology fellowship at Northwestern University. Dr. Yevzlin is Professor of Medicine and director of Interventional Nephrology at the University of Michigan.
Positions
- Company NameSigyn Therapeutics, Inc.Stock CodeSIGYPositionMember of Scientific Advisory Board
